These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

588 related items for PubMed ID: 16142315

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The usefulness of digital subtraction imaging with Levovist in the diagnosis of focal hepatic tumors.
    Yamamoto K, Shiraki K, Nakanishi S, Deguchi M, Sugimoto K, Sakai T, Ohmori S, Murata K, Fuke H, Hashimoto A, Shimizu A, Okuda Y, Nakano T.
    Int J Oncol; 2003 Feb; 22(2):353-8. PubMed ID: 12527934
    [Abstract] [Full Text] [Related]

  • 3. Imaging of benign hypervascular hepatocellular nodules in alcoholic liver cirrhosis: differentiation from hypervascular hepatocellular carcinoma.
    Kobayashi S, Matsui O, Kamura T, Yamamoto S, Yoneda N, Gabata T, Terayama N, Sanada J.
    J Comput Assist Tomogr; 2007 Feb; 31(4):557-63. PubMed ID: 17882031
    [Abstract] [Full Text] [Related]

  • 4. Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?
    Chung JJ, Kim MJ, Kim KW.
    J Magn Reson Imaging; 2006 May; 23(5):706-11. PubMed ID: 16565954
    [Abstract] [Full Text] [Related]

  • 5. Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid.
    Hatanaka K, Kudo M, Minami Y, Ueda T, Tatsumi C, Kitai S, Takahashi S, Inoue T, Hagiwara S, Chung H, Ueshima K, Maekawa K.
    Intervirology; 2008 May; 51 Suppl 1():61-9. PubMed ID: 18544950
    [Abstract] [Full Text] [Related]

  • 6. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreiländertreffen 2008, Davos.
    Seitz K, Strobel D, Bernatik T, Blank W, Friedrich-Rust M, Herbay Av, Dietrich CF, Strunk H, Kratzer W, Schuler A.
    Ultraschall Med; 2009 Aug; 30(4):383-9. PubMed ID: 19688670
    [Abstract] [Full Text] [Related]

  • 7. 1.5 Harmonic Imaging Sonography with microbubble contrast agent improves characterization of hepatocellular carcinoma.
    Yamamoto K, Shiraki K, Nakanishi S, Fuke H, Nakano T, Hashimoto A, Shimizu A, Hamataki T.
    World J Gastroenterol; 2005 Sep 28; 11(36):5607-13. PubMed ID: 16237752
    [Abstract] [Full Text] [Related]

  • 8. Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging.
    Yu JS, Lee JH, Chung JJ, Kim JH, Kim KW.
    Acta Radiol; 2008 Sep 28; 49(7):735-43. PubMed ID: 18608015
    [Abstract] [Full Text] [Related]

  • 9. Phase inversion harmonic imaging versus contrast-enhanced power Doppler sonography for the characterization of focal liver lesions.
    Strobel D, Raeker S, Martus P, Hahn EG, Becker D.
    Int J Colorectal Dis; 2003 Jan 28; 18(1):63-72. PubMed ID: 12458384
    [Abstract] [Full Text] [Related]

  • 10. Prospective study of differential diagnosis of hepatic tumors by pattern-based classification of contrast-enhanced sonography.
    Numata K, Isozaki T, Morimoto M, Sugimori K, Kunisaki R, Morizane T, Tanaka K.
    World J Gastroenterol; 2006 Oct 21; 12(39):6290-8. PubMed ID: 17072951
    [Abstract] [Full Text] [Related]

  • 11. Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography.
    Wen YL, Kudo M, Zheng RQ, Minami Y, Chung H, Suetomi Y, Onda H, Kitano M, Kawasaki T, Maekawa K.
    AJR Am J Roentgenol; 2003 Jul 21; 181(1):57-63. PubMed ID: 12818830
    [Abstract] [Full Text] [Related]

  • 12. Optimal acquisition delay for dynamic contrast-enhanced MRI of hypervascular hepatocellular carcinoma.
    Goshima S, Kanematsu M, Kondo H, Shiratori Y, Onozuka M, Moriyama N, Bae KT.
    AJR Am J Roentgenol; 2009 Mar 21; 192(3):686-92. PubMed ID: 19234264
    [Abstract] [Full Text] [Related]

  • 13. Hepatic hemangioma and metastasis: differentiation with gadoxetate disodium-enhanced 3-T MRI.
    Goshima S, Kanematsu M, Watanabe H, Kondo H, Shiratori Y, Onozuka M, Moriyama N.
    AJR Am J Roentgenol; 2010 Oct 21; 195(4):941-6. PubMed ID: 20858822
    [Abstract] [Full Text] [Related]

  • 14. Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma.
    Rimola J, Forner A, Reig M, Vilana R, de Lope CR, Ayuso C, Bruix J.
    Hepatology; 2009 Sep 21; 50(3):791-8. PubMed ID: 19610049
    [Abstract] [Full Text] [Related]

  • 15. [Usefulness of 3DFT-FISP MR imaging in differential diagnosis of liver tumor].
    Ishida T, Murakami T, Nakamura H, Tsuda K, Nakanishi K, Hori S, Tomoda K, Mitani T, Hashimoto T, Kozuka T.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Feb 25; 54(2):101-8. PubMed ID: 8121775
    [Abstract] [Full Text] [Related]

  • 16. Dual double arterial phase dynamic MR imaging with sensitivity encoding (SENSE): which is better for diagnosing hypervascular hepatocellular carcinomas, in-phase or opposed-phase imaging?
    Yoshioka H, Sato J, Takahashi N, Lou D, Yamaguchi M, Saida Y, Itai Y.
    Magn Reson Imaging; 2004 Apr 25; 22(3):361-7. PubMed ID: 15062931
    [Abstract] [Full Text] [Related]

  • 17. How to characterize non-hypervascular hepatic nodules on contrast-enhanced computed tomography in chronic liver disease: feasibility of contrast-enhanced ultrasound with a microbubble contrast agent.
    Yoshizumi H, Maruyama H, Okugawa H, Kobayashi S, Akiike T, Yoshikawa M, Ebara M, Yokosuka O, Matsutani S, Kondo F, Kamiyama N.
    J Gastroenterol Hepatol; 2008 Oct 25; 23(10):1528-34. PubMed ID: 17944882
    [Abstract] [Full Text] [Related]

  • 18. Corona enhancement in ultrasonographical post-vascular phase images with microbubble contrast agent: a novel specific sign for hepatocellular carcinomas.
    Yamamoto K, Nakanishi S, Fuke H, Hashimoto A, Shimizu A, Hamataki T, Shiraki K.
    Oncol Rep; 2006 Apr 25; 15(4):785-90. PubMed ID: 16525659
    [Abstract] [Full Text] [Related]

  • 19. Diagnosis of hepatocellular carcinoma nodules in patients with chronic liver disease using contrast-enhanced sonography: usefulness of the combination of arterial- and kupffer-phase enhancement patterns.
    Suzuki K, Okuda Y, Ota M, Kojima F, Horimoto M.
    J Ultrasound Med; 2015 Mar 25; 34(3):423-33. PubMed ID: 25715363
    [Abstract] [Full Text] [Related]

  • 20. Prediction of viable tumor in hepatocellular carcinoma treated with transcatheter arterial chemoembolization: usefulness of attenuation value measurement at quadruple-phase helical computed tomography.
    Kim SH, Lee WJ, Lim HK, Lim JH.
    J Comput Assist Tomogr; 2007 Mar 25; 31(2):198-203. PubMed ID: 17414753
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.